zidovudine has been researched along with AIDS, Simian in 29 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 23 (79.31) | 18.2507 |
| 2000's | 3 (10.34) | 29.6817 |
| 2010's | 3 (10.34) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Benech, H; Bourry, O; Brochard, P; Calvo, J; Dereudre-Bosquet, N; Kazanji, M; Le Grand, R; Makuwa, M; Martinon, F; Souquiere, S | 1 |
| Benech, H; Bourry, O; Dereuddre-Bosquet, N; Durand-Gasselin, L; Le Grand, R; Mannioui, A; Roques, P; Roucairol, C; Sellier, P | 1 |
| Bourry, O; Brown, C; Dejucq-Rainsford, N; Deleage, C; Denis, H; Deureuddre-Bosquet, N; Le Grand, R; Le Tortorec, A; Moreau, M; Roques, P; Satie, AP | 1 |
| Didier, PJ; Michael, H; Mitsuya, H; Murphey-Corb, M; Nyaundi, J; Parniak, MA; Rajakumar, P; Reeve, AB; Sarafianos, SG | 1 |
| Chuang, LF; Chuang, RY; Chuang, TK; Doi, RH; Miyagi, T; Suzuki, S | 1 |
| Chackerian, B; Haigwood, NL; Overbaugh, J | 1 |
| Baskin, GB; Davison-Fairburn, B; Martin, LN; Murphey-Corb, M; Soike, KF | 1 |
| Chuang, AJ; Chuang, RY; Killam, KF | 1 |
| Marthas, ML; McChesney, MB; Miller, CJ; Otsyula, MG; Pedersen, NC; Van Rompay, KK | 1 |
| Eiden, LE; Heyes, MP; Murray, EA; Rausch, DM | 1 |
| Marthas, ML; Van Rompay, K | 1 |
| Chandrasena, G; Ho, RJ; Qian, M; Unadkat, JD | 1 |
| Clayette, P; Dormont, D; Le Grand, R; Michel, G; Noack, O; Roques, P; Theodoro, F; Vaslin, B | 1 |
| Eiden, LE; Heyes, M; Rausch, DM | 1 |
| Marthas, ML; Pedersen, NC; van Rompay, KK | 1 |
| da Cunha, A; Eiden, LE; Heyes, M; Murray, EA; Nohr, D; Rausch, DM; Sharer, L; Weihe, E | 1 |
| Chuang, AJ; Chuang, RY; Killam, KF; Kun, E; Mendeleyev, J; Rice, WG; Schaeffer, CA | 1 |
| Bartz, CR; Benveniste, RE; Follis, KE; Grant, RF; Nolte, RE; Sager, PR; Tsai, CC | 1 |
| Farzadegan, H; Flexner, C; McEntee, MF; Narayan, O; Pitha, P | 1 |
| Benveniste, O; Clayette, P; Dormont, D; Frétier, P; Le Grand, R; Le Naour, R; Noack, O; Théodoro, F; Vaslin, B | 1 |
| Greenier, JL; Marthas, ML; Miller, CJ; Otsyula, MG; Pedersen, NC; Tarara, RP; Van Rompay, KK | 1 |
| Clayette, P; Dereuddre-Bosquet, N; Dormont, D; Jorajuria, S; Larghero, J; Le Grand, R; Neildez, O; Thiebot, H; Vaslin, B | 1 |
| Böttiger, D; Li, SL; Oberg, B; Ståhle, L | 1 |
| Joye, SM; Mandell, CP; Marthas, ML; McGowan, EK; Pedersen, NC; Ramos, RA; Van Rompay, KK | 1 |
| Böttiger, D; Guzenda, E; Ljungdahl-Ståhle, E; Oberg, B; Ståhle, L; Wahren, B | 1 |
| Wyand, MS | 1 |
| Fazely, F; Haseltine, WA; Rodger, RF; Ruprecht, RM | 1 |
| Böttiger, D; Ljungdahl-Ståhle, E; Lundgren, B; Norrby, E; Oberg, B; Ståhle, L; Wahren, B | 1 |
3 review(s) available for zidovudine and AIDS, Simian
| Article | Year |
|---|---|
Opioids and the progression of simian AIDS.
Topics: Animals; Disease Progression; Humans; Immune System; Macaca mulatta; Morphine; Mutation; Narcotics; Simian Acquired Immunodeficiency Syndrome; Simian Immunodeficiency Virus; Virus Replication; Zidovudine | 2005 |
AIDS and the central nervous system. Examining pathobiology and testing therapeutic strategies in the SIV-infected rhesus monkey.
Topics: Acquired Immunodeficiency Syndrome; Animals; Animals, Newborn; Central Nervous System; Humans; Macaca mulatta; Simian Acquired Immunodeficiency Syndrome; Zidovudine | 1993 |
The use of SIV-infected rhesus monkeys for the preclinical evaluation of AIDS drugs and vaccines.
Topics: AIDS Vaccines; Animals; Antiviral Agents; Drug Evaluation, Preclinical; Macaca mulatta; Simian Acquired Immunodeficiency Syndrome; Simian Immunodeficiency Virus; Zidovudine | 1992 |
26 other study(ies) available for zidovudine and AIDS, Simian
| Article | Year |
|---|---|
Prevention of vaginal simian immunodeficiency virus transmission in macaques by postexposure prophylaxis with zidovudine, lamivudine and indinavir.
Topics: Administration, Oral; Animals; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; CD4 Lymphocyte Count; Disease Models, Animal; Drug Evaluation, Preclinical; Female; Indinavir; Injections, Subcutaneous; Lamivudine; Macaca fascicularis; Sexually Transmitted Diseases, Viral; Simian Acquired Immunodeficiency Syndrome; Vagina; Viral Load; Viremia; Zidovudine | 2009 |
Effect of a short-term HAART on SIV load in macaque tissues is dependent on time of initiation and antiviral diffusion.
Topics: Administration, Cutaneous; Administration, Oral; Animals; Antiretroviral Therapy, Highly Active; Drug Administration Schedule; HIV Protease Inhibitors; Indinavir; Lamivudine; Macaca fascicularis; Male; Reverse Transcriptase Inhibitors; Simian Acquired Immunodeficiency Syndrome; Simian Immunodeficiency Virus; Time Factors; Tissue Distribution; Viremia; Zidovudine | 2010 |
Impact of short-term HAART initiated during the chronic stage or shortly post-exposure on SIV infection of male genital organs.
Topics: Animals; Antiretroviral Therapy, Highly Active; Genitalia, Male; Indinavir; Lamivudine; Macaca fascicularis; Male; RNA, Viral; Semen; Simian Acquired Immunodeficiency Syndrome; Simian Immunodeficiency Virus; Viral Load; Zidovudine | 2012 |
Response of simian immunodeficiency virus to the novel nucleoside reverse transcriptase inhibitor 4'-ethynyl-2-fluoro-2'-deoxyadenosine in vitro and in vivo.
Topics: Adenine; Animals; Antiviral Agents; Cells, Cultured; Deoxyadenosines; Deoxycytidine; Emtricitabine; Leukocytes, Mononuclear; Macaca mulatta; Male; Mutation; Organophosphonates; Recurrence; Reverse Transcriptase Inhibitors; RNA-Directed DNA Polymerase; Simian Acquired Immunodeficiency Syndrome; Simian Immunodeficiency Virus; Tenofovir; Viral Load; Zidovudine | 2012 |
Characterization of a CD4-expressing macaque cell line that can detect virus after a single replication cycle and can be infected by diverse simian immunodeficiency virus isolates.
Topics: Animals; beta-Galactosidase; CD4 Antigens; Clone Cells; Genetic Engineering; HIV Long Terminal Repeat; HIV-1; HIV-2; Humans; Macaca mulatta; Macaca nemestrina; Mammary Neoplasms, Animal; Neutralization Tests; Simian Acquired Immunodeficiency Syndrome; Simian Immunodeficiency Virus; Tumor Cells, Cultured; Virion; Virus Replication; Zidovudine | 1995 |
Effects of initiation of 3'-azido,3'-deoxythymidine (zidovudine) treatment at different times after infection of rhesus monkeys with simian immunodeficiency virus.
Topics: Animals; Antigens, CD; Antigens, Viral; Biomarkers; CD4 Antigens; Drug Administration Schedule; Female; Hematocrit; Injections, Subcutaneous; Integrin beta1; Lymphocyte Subsets; Macaca mulatta; Male; Simian Acquired Immunodeficiency Syndrome; Simian Immunodeficiency Virus; Time Factors; Zidovudine | 1993 |
Reduced sensitivity to AZT of SIV isolates from morphine treated rhesus monkeys.
Topics: Animals; Cell Fusion; Cell Line; Cytopathogenic Effect, Viral; Drug Resistance, Microbial; Macaca mulatta; Morphine; RNA-Directed DNA Polymerase; Simian Acquired Immunodeficiency Syndrome; Simian Immunodeficiency Virus; Zidovudine | 1993 |
Immediate zidovudine treatment protects simian immunodeficiency virus-infected newborn macaques against rapid onset of AIDS.
Topics: Administration, Oral; Animals; Animals, Newborn; Antibodies, Viral; CD4-CD8 Ratio; Macaca mulatta; Models, Biological; Simian Acquired Immunodeficiency Syndrome; Simian Immunodeficiency Virus; Zidovudine | 1995 |
Zidovudine treatment prolongs survival and decreases virus load in the central nervous system of rhesus macaques infected perinatally with simian immunodeficiency virus.
Topics: Animals; CD4-CD8 Ratio; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Central Nervous System; Cerebrospinal Fluid; Death; Female; Macaca mulatta; Male; Motor Activity; Quinolinic Acid; Simian Acquired Immunodeficiency Syndrome; Simian Immunodeficiency Virus; Time Factors; Viral Core Proteins; Zidovudine | 1995 |
"The Duesberg phenomenon": what does it mean?
Topics: Acquired Immunodeficiency Syndrome; Animals; Animals, Newborn; Disease Models, Animal; Humans; Macaca mulatta; Simian Acquired Immunodeficiency Syndrome; Simian Immunodeficiency Virus; Zidovudine | 1995 |
Comparison of rates of intracellular metabolism of zidovudine in human and primate peripheral blood mononuclear cells.
Topics: Animals; Dose-Response Relationship, Drug; HIV Infections; Humans; Leukocytes, Mononuclear; Macaca nemestrina; Phosphorylation; Simian Acquired Immunodeficiency Syndrome; Zidovudine | 1994 |
An animal model for antilentiviral therapy: effect of zidovudine on viral load during acute infection after exposure of macaques to simian immunodeficiency virus.
Topics: Acquired Immunodeficiency Syndrome; Animals; Antibodies, Viral; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; HIV-1; Humans; Macaca fascicularis; Simian Acquired Immunodeficiency Syndrome; Simian Immunodeficiency Virus; T-Lymphocyte Subsets; Virion; Zidovudine | 1994 |
Effects of chronic zidovudine administration on CNS function and virus burden after perinatal SIV infection in rhesus monkeys.
Topics: Animals; Animals, Newborn; Antigens, Viral; Cognition; Macaca mulatta; Motor Activity; Nervous System Diseases; Quinolinic Acid; Simian Acquired Immunodeficiency Syndrome; Simian Immunodeficiency Virus; Zidovudine | 1994 |
Prophylactic ZDV dosing frequency in macaques.
Topics: Animals; Macaca mulatta; Simian Acquired Immunodeficiency Syndrome; Viremia; Zidovudine | 1994 |
Inhibition of the replication of native and 3'-azido-2',3'-dideoxythymidine (AZT)-resistant simian immunodeficiency virus (SIV) by 3-nitrosobenzamide.
Topics: Animals; Antiviral Agents; Benzamides; Cell Line; DNA, Viral; Drug Resistance, Microbial; Genes, gag; Humans; Macaca mulatta; Nitroso Compounds; Polymerase Chain Reaction; Simian Acquired Immunodeficiency Syndrome; Simian Immunodeficiency Virus; Virus Replication; Zidovudine | 1993 |
Effect of dosing frequency on ZDV prophylaxis in macaques infected with simian immunodeficiency virus.
Topics: Anemia; Animals; Antibodies, Viral; Base Sequence; DNA Primers; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Follow-Up Studies; Leukocytes, Mononuclear; Lymph Nodes; Lymphocyte Subsets; Macaca fascicularis; Male; Molecular Sequence Data; Polymerase Chain Reaction; Simian Acquired Immunodeficiency Syndrome; Simian Immunodeficiency Virus; Time Factors; Viremia; Zidovudine | 1993 |
Comparison of the effects of 3'-azidothymidine with those of neutralizing antibodies on simian immunodeficiency virus infection in macrophages.
Topics: Animals; Antibodies, Viral; Cytokines; Cytopathogenic Effect, Viral; In Vitro Techniques; Macaca mulatta; Macrophages; Simian Acquired Immunodeficiency Syndrome; Simian Immunodeficiency Virus; Viral Proteins; Virus Replication; Zidovudine | 1993 |
Tumor necrosis factor-alpha in serum of macaques during SIVmac251 acute infection.
Topics: Acquired Immunodeficiency Syndrome; Animals; Antiviral Agents; Biomarkers; Disease Models, Animal; Female; HIV; Humans; Macaca fascicularis; Male; Simian Acquired Immunodeficiency Syndrome; Simian Immunodeficiency Virus; Time Factors; Tumor Necrosis Factor-alpha; Viremia; Virus Replication; Zidovudine | 1995 |
A zidovudine-resistant simian immunodeficiency virus mutant with a Q151M mutation in reverse transcriptase causes AIDS in newborn macaques.
Topics: Animals; Animals, Newborn; Antiviral Agents; Drug Resistance, Microbial; Drug Resistance, Multiple; Macaca mulatta; Point Mutation; RNA-Directed DNA Polymerase; Simian Acquired Immunodeficiency Syndrome; Simian Immunodeficiency Virus; Virulence; Zidovudine | 1997 |
HE2000 shows efficacy.
Topics: Animals; Anti-HIV Agents; Disease Models, Animal; Drugs, Investigational; Haplorhini; Lamivudine; Ritonavir; Simian Acquired Immunodeficiency Syndrome; Survival Analysis; Viral Load; Zidovudine | 1999 |
[Evaluation of the effect of early and massive tritherapy on the expression of cellular factors potentially implicated in antiretroviral therapy resistance].
Topics: Animals; Anti-HIV Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Drug Resistance, Microbial; Gene Expression; Indinavir; Lamivudine; Macaca fascicularis; Male; Nucleoside-Phosphate Kinase; RNA, Messenger; Simian Acquired Immunodeficiency Syndrome; Thymidine Kinase; Zidovudine | 2000 |
Long-term tolerance and efficacy of 3'-azidothymidine and 3'-fluorothymidine treatment of asymptomatic monkeys infected with simian immunodeficiency virus.
Topics: Anemia; Animals; Antiviral Agents; Blood Cell Count; CD4 Antigens; Dideoxynucleosides; Enzymes; Leukopenia; Macaca fascicularis; Simian Acquired Immunodeficiency Syndrome; Zidovudine | 1992 |
Simian immunodeficiency virus (SIV) infection of infant rhesus macaques as a model to test antiretroviral drug prophylaxis and therapy: oral 3'-azido-3'-deoxythymidine prevents SIV infection.
Topics: Administration, Oral; Animals; Animals, Suckling; Disease Models, Animal; Injections, Intravenous; Macaca mulatta; Simian Acquired Immunodeficiency Syndrome; Simian Immunodeficiency Virus; Time Factors; Zidovudine | 1992 |
Penetration of zidovudine and 3'-fluoro-3'-deoxythymidine into the brain, muscle tissue, and veins in cynomolgus monkeys: relation to antiviral action.
Topics: Animals; Antiviral Agents; Blood-Brain Barrier; Brain; Dialysis; Dideoxynucleosides; Extracellular Space; Macaca fascicularis; Muscles; Simian Acquired Immunodeficiency Syndrome; Simian Immunodeficiency Virus; Tissue Distribution; Veins; Virus Replication; Zidovudine | 1992 |
Postexposure chemoprophylaxis with ZDV or ZDV combined with interferon-alpha: failure after inoculating rhesus monkeys with a high dose of SIV.
Topics: Animals; Drug Synergism; Drug Therapy, Combination; Female; Interferon Type I; Macaca mulatta; Male; Recombinant Proteins; Simian Acquired Immunodeficiency Syndrome; Simian Immunodeficiency Virus; Zidovudine | 1991 |
Antiviral effects of 3'-fluorothymidine and 3'-azidothymidine in cynomolgus monkeys infected with simian immunodeficiency virus.
Topics: Animals; Antibodies, Viral; Antigens, Viral; Cells, Cultured; Dideoxynucleosides; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Drug Therapy, Combination; Humans; Macaca fascicularis; Simian Acquired Immunodeficiency Syndrome; Simian Immunodeficiency Virus; Viral Envelope Proteins; Zidovudine | 1991 |